Retatrutide API Raw Material Peptide Powder | CAS 2381089-83-2

Retatrutide is a peptide composed of 39 amino acids, belonging to the GLP-1R/GIPR/GCGR triple receptor agonist class.

The design inspiration for Retatrutide comes from endogenous intestinal insulinotropic hormones (such as GIP), and through structural optimization, it can simultaneously activate the following three receptors: GLP-1 receptor (GLP-1 R): promotes insulin secretion, inhibits glucagon release, delays gastric emptying, and enhances satiety.

The multi-target synergistic effect of ritaglutide demonstrates superior potential in metabolic regulation compared to traditional GLP-1 single target drugs such as semaglutide and liraglutide, particularly in weight loss, blood sugar reduction, and liver fat improvement.

Retatrutide API Peptide Synthesis

Retatrutide is produced using solid-phase peptide synthesis, requiring strict control of parameters such as temperature and pH, followed by purification via high-performance liquid chromatography to obtain the final product.

Omizzur Peptide provides a large supply of various peptide APIs, peptide impurities, and GLP-1 intermediates. Omizzur also accept customized peptide synthesis projects. Please consult Omizzur services for details.

>>Omizzur Hot Peptide Catalog

*** For more peptide catalog please get in touth with Omizzur team:  [email protected]

The future development direction and potential of Retatrutide

Retatrutide has shown broad application prospects in the treatment of obesity, type 2 diabetes and other metabolic diseases. In the treatment of obesity, its significant weight loss effect makes it a promising first-line treatment drug, helping more obese patients achieve healthy weight loss. For patients with type 2 diabetes, it can not only effectively control blood sugar, but also improve insulin resistance and beta cell function, providing patients with a more comprehensive treatment plan.

Retatrutide also has potential therapeutic value in other metabolic diseases, such as non-alcoholic steatohepatitis (NASH) and reduced cardiovascular risk. Its positive effects on blood lipid profile, blood pressure, and liver fat accumulation have brought new hope for the treatment of these diseases.

In the future, the R&D team can also explore higher doses of ritaglutide to further improve therapeutic efficacy. At the same time, conducting research on combination therapy and synergistic effects with other drugs to enhance treatment efficacy. In addition, the research and development of oral formulations is also an important direction. If successful export of ritaglutide can be developed, Retatrutide will greatly improve the convenience of medication for patients and further expand its market potential.

Photos of Omizzur Peptide Products

Retatrutide Peptide API Raw Material Powder High Purity Buy Online

 Order Retatrutide now:

 1. Click to send inqauiry online:  Make Inquiry Now 

 2. Send mail to us: [email protected]

  * Please mail us your address and quantity needed, Omizzur services will get back to you within 1~2 hours.

About Omizzur Ltd

Omizzur specializes in custom peptide synthesis, providing professional peptide synthesis services to pharmaceutical R&D companies worldwide. Our product offerings include pharmaceutical-grade peptides, cosmetic peptides, peptide impurity synthesis, and amino acid derivatives. For more peptide product information, please contact Omizzur custom peptide synthesis.